Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

National Institutes of Health

MODERATE Tx General

Strategy Notes

—

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: 08/18/2026
Cycle: —
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-22 OPEN → INELIGIBLE · The Blueprint Neurotherapeutics Network (BPN) is a U.S. federal grant program that typically requires the applicant to be a U.S.-based institution or have a significant U.S. institutional affiliation. Eniola is an independent researcher based in Nigeria with no U.S. institutional affiliation, and the program does not appear to support individual foreign applicants without a U.S. partner institution.